The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer have?
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer has 707 citations in the OpenAlex counts ScholarIQ stores.
When was The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer published?
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer has 2021 year in the ScholarIQ index.
What is the open-access status of The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer?
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer has green oa status in the ScholarIQ index.
What is the DOI of The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer?
The DOI for The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer is on the source record.
What is the PMID of The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer?
The PMID for The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer is on the source record.
What is the OpenAlex record for The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer?
The OpenAlex for The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer is on the source record.